Log in to save to my catalogue

Use of Polyamidoamine Dendrimers in Brain Diseases

Use of Polyamidoamine Dendrimers in Brain Diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8c287c3dac0e4ffeb2da55bb19461474

Use of Polyamidoamine Dendrimers in Brain Diseases

About this item

Full title

Use of Polyamidoamine Dendrimers in Brain Diseases

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2018-09, Vol.23 (9), p.2238

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Polyamidoamine (PAMAM) dendrimers are one of the smallest and most precise nanomolecules available today, which have promising applications for the treatment of brain diseases. Each aspect of the dendrimer (core, size or generation, size of cavities, and surface functional groups) can be precisely modulated to yield a variety of nanocarriers for de...

Alternative Titles

Full title

Use of Polyamidoamine Dendrimers in Brain Diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8c287c3dac0e4ffeb2da55bb19461474

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8c287c3dac0e4ffeb2da55bb19461474

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules23092238

How to access this item